Lucid Diagnostics Inc. (NASDAQ: LUCD) Stock Information | RedChip

Lucid Diagnostics Inc. (NASDAQ: LUCD) Listen to this Section


$0.82
-0.0145 ( -1.74% ) 69.6K

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Market Data


Open


$0.82

Previous close


$0.84

Volume


69.6K

Market cap


$41.20M

Day range


$0.82 - $0.89

52 week range


$0.63 - $1.72

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 12 Nov 28, 2023
8-k 8K-related 12 Nov 24, 2023
8-k 8K-related 13 Nov 14, 2023
10-q Quarterly Reports 77 Nov 13, 2023
8-k 8K-related 12 Nov 13, 2023
8-k 8K-related 14 Oct 18, 2023
4 Insider transactions 1 Sep 27, 2023
4/a Other 1 Sep 27, 2023
4 Insider transactions 1 Sep 22, 2023
10-q Quarterly Reports 76 Aug 14, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.